Taking Action
Obesity Is a Chronic and Progressive Disease, but Is Often Not Treated the Same as Other Conditions in This Category1
Like for many multifactorial and chronic diseases,2 it is critical to offer both pharmacological and non-pharmacological options to your employees with obesity, as one specific strategy will not address the needs of everyone in your organization.3
TAKING ACTION
Obesity Is a Chronic and Progressive Disease, but Is Often Not Treated the Same as Other Conditions in This Category1
Like for many multifactorial and chronic diseases,2 it is critical to offer both pharmacological and non-pharmacological options to your employees with obesity, as one specific strategy will not address the needs of everyone in your organization.3
In addition to lifestyle intervention and bariatric surgery, coverage for anti-obesity medications (AOMs) is often a determining factor in the ability to appropriately manage weight at the employer level.1,4
The Cost of Obesity
Get 3 learning modules to better understand your next action steps for optimizing coverage for weight-loss treatments, including AOMs.
Additional Resources
Obesity Resources for Employees
Spanish Language Obesity Resources for Employees
Transportation Industry Obesity Education Program
Drive the Right Weigh Program
An informational program for transportation employers and employees to help educate about commercial driver’s license (CDL) driver health, productivity, and safety. Please contact an Account Manager for more information regarding this program.
Explore the Next Topic
Measuring Success
Measuring the success of adding AOM coverage as part of an overall obesity-management program is important for employee health.
Measuring Success
Measuring the success of adding AOM coverage as part of an overall obesity-management program is important for employee health.
Contact us to learn more
References: 1. Nobel J, Pickering L, Sasser E. Tipping the scales on weight control: new strategies for employers. Northeast Business Group on Health. Published August 2016. Accessed May 18, 2023. https://nebgh.org/wp-content/uploads/2016/08/NEBGH_Tipping-the-Scales-2016.pdf 2. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists’ position statement on obesity and obesity medicine. Endocr Pract. 2012;18(5):642-648. 3. Wadden TA, Berkowitz Rl, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111-2120. 4. Garvey WT, Mechanick JI, Brett EM, et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(suppl 3):1-203.
